NISSHA Expands Micro-Molding Capacity to Meet Growing Demand for Medical Device Miniaturization

Nissha Medical Technologies (NMT), the medical device contract design and manufacturing organization (CDMO) arm of NISSHA Co., Ltd., held a groundbreaking ceremony for a new facility in New Richmond, Wisconsin, to expand its micro-molding production capacity. This expansion is designed to strengthen production systems in response to growing demand for high-precision, small-scale components in the medical device sector.

The new facility, spanning approximately 4,650 square meters, is expected to be completed in April 2027, followed by a phased equipment installation for full-scale operation. NMT anticipates more than doubling its production capacity through this new facility. This will further enhance its ability to meet the needs for sophisticated and miniaturized medical devices, accelerating business growth.

NMT’s micro-molded products are used in a wide range of applications, including minimally invasive surgical tools such as endoscopic instruments, surgical robots, diagnostic equipment, and medical wearable sensors. These products are critical elements supporting the miniaturization and high-functionality of medical devices, helping to reduce physical burden on patients and improve convenience in medical settings.

Micro-molding refers to an injection molding process that forms minute shapes with dimensional precision at the micrometer level (1/1,000 of a millimeter). NISSHA Co., Ltd. is a manufacturer leveraging unique processing technologies, operating globally in three segments: Industrial Materials, Devices, and Medical. In the medical field, it primarily conducts CDMO business in North America, utilizing technologies such as plastic molding and metal processing.